37 results found.
4 pages of results.
... grants from the Leukemia and Lymphoma Society, American Cancer Society and National Cancer Institute REVLIMID(R) New Drug Application Submitted to FDA for Review Clinical Data From Phase ...
Score: 20 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0032.htm
... online, Israel business news- www.globes.co.il- on Wednesday, February 16, 2005 REVLIMID(R) New Drug Application Submitted to FDA for Review Clinical Data From Phase ...
Score: 20 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0029.htm
... counter product. Their lives literally may depend on it," Smith said. REVLIMID(R) New Drug Application Submitted to FDA for Review Clinical Data From Phase ...
Score: 20 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0003.htm
... usually given as part of a clinical trial. Information about the new drug, REVLIMID® REVLIMID® is the lead investigational development compound of a new class of novel ...
Score: 18 - 5 Feb 2007 - URL: http://www.leukemia-web.org/mds-myelodysplastic-syndrome.htm
... ), paroxysmal nocturnal hemoglobinuria (PNH) and other bone marrow failure diseases. Revlimid approved by the FDA In clinical trials most patients treated with Revlimid® no longer ...
Score: 15 - 5 Feb 2007 - URL: http://www.aplastic-anemia.org/aplastic-anemia-news.htm
... update forward-looking statements.---- Source: Structural GenomiX, Inc. Revlimid, as oral treatment regimen in chronic lymphocytic leukemia The clinical data from a Revlimid ...
Score: 14 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0099.htm
... of scientific data integrated with expert judgment. The NCCN expert panel recommends lenolidamide (Revlimid, Celgene) for the treatment of patients with myelodysplastic syndrome who have an abnormality ...
Score: 10 - 5 Feb 2007 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0132.htm
... Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS) ...
Score: 8 - 26 Sep 2006 - URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0023.htm
... disorders that can develop into acute myeloid leukemia. The drug, called lenalidomide or Revlimid, may help some patients reduce their need for blood transfusions or avoid them altogether ...
Score: 8 - 8 Dec 2006 - URL: http://www.aplastic-anemia.org/aplastic-anemia-news/aplastic-anemia-news-0010.htm
... Population Offers Commercial Opportunity to their offering. SuperGen/MGI Pharmas Dacogen and Celgenes Revlimid are in pre-registration for treatment of myelodysplastic syndrome (MDS). However, the ...
Score: 8 - 8 Dec 2006 - URL: http://www.aplastic-anemia.org/aplastic-anemia-news/aplastic-anemia-news-0081.htm
Leukemia Cancer Information